[1] 窦红涛,朱任媛,王瑶,等.1472株酵母菌的菌株鉴定与药敏分析[J].中华医院感染学杂志,20l0, 20:1978-1979.
[2] Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms[J]. Clinical microbiology reviews, 2002, 15(2):167-193.
[3] Wu JA, Attele AS,Zhang L. Anti-HIV activity of medicinal herbs: usage and potential devdopment[J]. Am J Clin Med,2001, 29:69-81.
[4] 沈雯,陆福明,顾勇,等.BAI对高糖诱导近端肾小管上皮细胞外基质及转化生长因子岛表达的影响[J].中华肾脏病杂志,2003, 19(3): 173-176.
[5] 董庆华,郑树,徐荣臻.黄芩苷元选择性诱导人的血病K562细胞凋亡[J].药学学报,2003, 38(11): 817-820.
[6] Lee HZ, Leung HW, Lai MY. Baiealein induced cell cycle and apoptosis in human lung squamom carcinoma CH27 cells[J]. Antieancer Res,2005, 25(2): 959-964.
[7] Taniguchi H, Yoshida T, Horinaka M. Baicalein overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells[J]. Cancer Res,2008, 68:8918-8927.
[8] 周立剐,张颖君,蔡艳,等.黄酮和甾体类化合物的抗真菌活性[J].天然产物研究与开发,1997, 9(3): 24-29.
[9] 杨得坡,胡海燕,黄世亮.黄芩甙元和黄芩甙对皮肤真菌与细菌抑制作用的研究[J].中药材,2000, 23(5): 272-274.
[10] Chandra JDM, Kuhn PK, Mukherjee LL, et al. Biofilm formation by the fungal pathogen Candida albicans:development, architecture, and drug resistance[J]. J Bacteriol, 2001, 183:5385-5394.
[11] Klotz SA, Drutz DJ, Zajic JE. Factors governing adherence of Candida species to plastic surfaces[J]. Infect Immun, 1985, 50: 97-101.
[12] Wang Y, Cao YY, Jia XM, et al. Cap1p is involved in multiple pathways of oxidative stress response in Candida albicans[J]. Free Radical Biol Med, 2006, 40:1201-1209.
[13] Chandra J, Kuhn DM, Mukherjee PK, et al. Biofilm formation by the fungal pathogen Candida albicans:development, architecture, and drug resistance[J]. J Bacteriol,2001, 183(18):5385-5394.
[14] Tobudic S, Lassnigg A, Kratzer C, et al. Antifungal activity of amphotericin B, caspofungin and posaconazole on Candida albicans biofilms in intermediate and mature development phases[J]. Mycoses, 2010, 53(03):208-214.
[15] Kuhn DM, George T, Chandra J, et al. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins[J]. Antimicrob Agents Chemother, 2002, 46(06):1773-1780.
[16] Ramage G, Jose A, Coco B, et al. Commercial mouthwashes are more effective than azole antifungals against Candida albicans biofilms in vitro[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2011, 111(04):456-460.
[17] Reynolds TB, Fink GR. Bakers' yeast, a model for fungal biofilm formation[J]. Science, 2001, 291: 878-881.
[18] Li X, Yan Z, Xu J. Quantitative variation of biofilms among strains in natural populations of Candida albicans[J]. Microbiology, 2003, 149: 353-362.
[19] Singleton DR, Masuoka J, Hazen KC. Cloning and analysis of a Candida albicans gene that affects cell surface hydrophobicity[J]. J Bacteriol, 2001, 183: 3582-3588.
[20] Zheng X, Wang Y, Wang Y. Hgcl, a novel hypha-specific G1 cyclin-related protein regulates Candida albicans hyphal morpathogenesis[J]. EMBO J, 2004, 23(8):1845-1856.
[21] 王英,顾军.白念珠菌黏附机制研究进展[J].国外医学皮肤性病学分册,2001, 27(2):101-104. |